GL Capital Raises Stake in Sciclone Pharmaceuticals, Inc. (SCLN) to 7.07%
Tweet Send to a Friend
In an amended 13D filing on Sciclone Pharmaceuticals, Inc. (Nasdaq: SCLN), Zhenfu Li's hedge fund GL Capital Management Ltd. disclosed ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
